Evidence map›Paper›PMID 41155707›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Correction: Li et al. The Therapeutic Potential of Four Main Compounds of

Xiaohan Li, Qi Wang, Ling Liu, Yang Shi, Yang Hong, Wanqing Xu, Henghui Xu, Jing Feng, Minzhen Xie, Yang Li and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Xiaohan LiDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Qi WangDepartment of Medicinal Chemistry and Natural Medicinal Chemistry, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Ling LiuDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Yang ShiDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Yang HongDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Wanqing XuDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Henghui XuDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Jing FengDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Minzhen XieDepartment of Medicinal Chemistry and Natural Medicinal Chemistry, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Yang LiDepartment of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Harbin 150081, China.ORCID 0000-0002-0677-3245
Baofeng YangDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Yong ZhangDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.ORCID 0000-0002-8754-8938

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41155707
PMCPMC12566983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.